Navigation Links
CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market
Date:12/1/2008

According to CBDM.T®, the market and business intelligence company, the biofuel market is estimated at 33 billion with a double digit annual growth. The market consists of approximately 85% bioethanol and 15% biodiesel. Bioethanol is produced and consumed mainly in Brazil and North America. On the other hand, Europe is the world leader in biodiesel production and this fuel represents about ¾ of the European biofuels market.

Paris, France (PRWEB) November 27, 2008 -- Biofuels are fuels produced from renewable resources (organic material), especially plant biomass, vegetable oils, and treated municipal and industrial waste. Today the most important and commonly used biofuels are biodiesel derived from vegetable oil and ethanol derived from sugar and starch crops. These fuels are used to complement the world's supply of petroleum and other fossil fuels. Of all the alternative fuels, or biofuels, that are available or developed, the most significant market is for bioethanol. Global fuel ethanol production grew 25% in 2007 to more than 50 billion litres. The USA (production mostly from corn) and Brazil (production mostly from sugarcane) account for 91% of global bioethanol production, up from 89% in 2006. More recently, Asia (especially China, India and Thailand) has also embarked on large scale fuel-ethanol production and represents one of the largest production potential in the coming years. In 2007, the production of bioethanol in China amounted to 1.8 billion litres, thereby placing the country at rank 3 worldwide, ahead of the EU.

First generation bioethanol was made from food crops, but it is not believed that diverting food crops to create fuels will be sustainable over the long-term. And again, biotechnology, the 21th century technologic breakthrough, is one of the most effective and innovative technologies to develop second generation biofuels. Research is under way to commercialise 'second-generation' production techniques that can make biofuels from woody material, grasses, agricultural and some additional types of non food plant waste.

Biomass is a complex material composed of cellulose (30-50%), hemicellulose (20-40%), and lignin (15-30%). The exact composition varies from plant to plant. Since it is found in nearly all plant life, cellulose is the most abundant biological molecule on earth. Like the starch found in corn kernels, cellulose is a polymer of the sugar glucose. It forms part of the cell wall and is designed to contribute to the structural integrity of the plant. Hemicellulose is a more random and amorphous structure of connected sugars.

There are several technical and economic challenges associated with the large-scale production of ethanol from cellulosic biomass, which includes: collection and transport of the biomass raw material, preprocessing or "pretreatment", enzymatic conversion of pretreated plant material to sugars, and the fermentation of a mixed sugar stream. Many advances have been made in each of these areas over the past several years, greatly improving the likelihood that cellulosic ethanol will become a commercial reality in the very near future.

In 2007, sales of enzymes to the bioethanol industry comprised 13% of Novozymes'total enzymes sales. Enzymes for bioethanol is the fastest-growing segment in the enzyme market (an average increase in sales of 20-25% annually is expected over the next 3-4 years).

Biodiesel is emerging as a global industry. The EU currently represents 90% of global biodiesel production and consumption. However, the USA is now accelerating its biodiesel production capabilities. Biodiesel is a natural fit in Europe, Asia and Brazil where diesel-fuelled vehicles are more common than in the US. More than half of the biodiesel (nearly 3.3 billion litres) in the EU is produced in Germany. Germany is followed by France, Italy, and Austria with respectively 982, 410 and 301 million litres.

Biodiesel is currently produced from plant and animal oils. This could change in the near future with very promising ongoing development to produce biodiesel from microalgae. By containing 60 to 80% oil by weight of dry biomass and doubling their biomass within 24 hours, microalgae could revolutionise biofuel production.

According to CBDM.T®, the market and business intelligence company, the biofuel market is estimated at 33 billion with a double digit annual growth. The market consists of approximately 85% bioethanol and 15% biodiesel. Bioethanol is produced and consumed mainly in Brazil and North America. On the other hand, Europe is the world leader in biodiesel production and this fuel represents about three fourths of the European biofuels market. Only 1% of the world's energy supply is derived from ethanol or biodiesel. Market drivers for biofuels are oil supply and demand (prices, volatility), environmental concerns (emission of greenhouse gases and sustainability), national interests (security of supply, strategic independence, rural development opportunity) and biotechnological progress (better process, enzymes and microorganisms). But there are also inhibitors of the biofuels market such as infrastructures, process optimization and scalability, education, investment and implementation, and subsidies and tax incentives.

"Even if biotechnology brings effective solutions mainly for second generation biofuels, derived from non-food biomass, the expansion of biofuels production and consumption will definitely depend on governmental policies and fiscal incentives," comments Philippe Tramoy, managing partner.

Some key players: Archer Daniels Midland, Cargill, Verasun, Aventine, Abengoa Bioenergy, Bluefire, Iogen, Losonoco, Mascoma, Xethanol, Dong, DuPont/Poet, Tate & Lyle, Verenium, Novozymes, DSM, Codexis, Maxygen, Genencor, Dyadic, BP, Total, Chevron, Shell…

If you need market and business intelligence service in the biofuel market, please contact us at contact@cbdmt.com.

CBDM.T® - Market and Business Intelligence - is a Market and Business Intelligence Company with offices in France, Switzerland and in Israel. As an advisory services company, CBDM.T® boosts companies to develop revenue and growth by providing business and marketing services in the life science and biotech markets (market survey, market scouting, business development and strategic supports).

For more information:
CBDM.T® Market and Business Intelligence
88-90 rue de la Mare
Fr-75020 Paris - France
Tel : +33 1 4474 7957
Email: contact (at) cbdmt.com
Web site: CBDM.T®

CBDM.T® - Israel
POBox 6235
Netanya - 42490 - Israel
Tel: +972 52 3316190

To contact Philippe Tramoy directly

Our last focus:
Focus on White Biotechnology
Focus on Red Biotechnology
Focus on Green Biotechnology
Focus on Pharmaceutical Industry
Focus on Outsourcing In The Pharmaceutical Industry
Focus on Biofuels

###

Read the full story at http://www.prweb.com/releases/cbdmt/biofuel/prweb1673024.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market
2. CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market
3. CBDM.T, The Market and Business Intelligence Company Reviews The Enzyme Market
4. Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug
5. EastMed Inc. receives FDA clearance to market uresta(TM) in the U.S.
6. Advances in Detection Technology Drive the European Autoimmune Disease Diagnostics Market
7. Jazz Pharmaceuticals Cancels Presentation Planned for November 19, 2008 at Lazard Capital Markets 5th Annual Healthcare Conference
8. TechMandA.com Marketplace Streamlines M&A Process for Technology Businesses
9. Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
10. Gen-Probe to Webcast Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
11. Franklin & Seidelmann Adds Richard Dyke to Senior Management Team as Senior VP, Sales/Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market 
(Date:2/28/2017)... Feb. 28, 2017 Sangamo Therapeutics, Inc. ... today reported its fourth quarter and full year ... "Early this year we rebranded our company as ... of genomic therapies using our industry leading platform ... and cell therapy," said Sandy Macrae , ...
(Date:2/27/2017)... 2017 A Europe-wide survey of institutes conducted ... animals in their research treat them with due care. The survey ... analysis of the results indicates that there is a strong commitment ... into practice the principles of the 3Rs (Refine, Reduce, Replace)  ... What are the ...
(Date:2/27/2017)... PRINCETON, N.J. and HAMILTON, ... Advaxis, Inc. (NASDAQ: ADXS ) ... late-stage biopharmaceutical companies focused on developing cancer immunotherapies, ... license to develop a novel cancer immunotherapy agent ... technology with SELLAS, patented WT1 targeted heteroclitic peptide ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... Rob Lowe ... public television series. This series, called "Informed," focuses on issues that are important to ... on the climate change issue, which has been a hot topic around the world ...
Breaking Biology Technology:
(Date:2/2/2017)... , Feb. 1, 2017  Central to ... and meaningful advances worldwide, The Japan Prize Foundation ... Prize, who have pushed the envelope in their ... and Communication. Three scientists are being recognized with ... achievements that not only contribute to the advancement ...
(Date:1/26/2017)... , Jan. 26, 2017  Crossmatch, a leading ... a new solution aimed at combatting fraud, waste and ... was introduced at the Action on Disaster Relief conference ... meeting point for UN agencies and foreign assistance organizations ... Fraud, waste and abuse are a largely unacknowledged problem ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds simple ... sock that monitors vital signs and alerts parents ... infant,s oxygen saturation level drops. But pediatric experts ... to parents, with no evidence of medical benefits, ... are marketed aggressively to parents of healthy babies, ...
Breaking Biology News(10 mins):